1551 - 1560 of 6433 Results
Title
Year
- α‐Synuclein in Plasma‐Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease2021OPENTitle: α‐Synuclein in Plasma‐Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2508End Page: 2518Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28639Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28639Citation Count: 83
-
OPENTitle: Multimodal Longitudinal Neurophysiological Investigations in Dopa‐Responsive DystoniaJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1986End Page: 1987Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28679Best OA location URL: https://doi.org/10.1002/mds.28679Citation Count: 4
- CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLB2021OPENTitle: CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLBJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2595End Page: 2604Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28704Best OA location URL: https://pub.dzne.de/record/163488Citation Count: 19
-
OPENTitle: Systematic Assessment of 10 Biomarker Candidates Focusing on α‐Synuclein‐Related DisordersJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2874End Page: 2887Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28738Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28738Citation Count: 84
-
OPENTitle: Polyglutamine‐Expanded Ataxin‐3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral BloodJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2675End Page: 2681Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.28749Best OA location URL: https://doi.org/10.1002/mds.28749Citation Count: 30
-
OPENTitle: Abstracts of the MDS Virtual Congress 2021Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28794Citation Count: 33
-
OPENTitle: Pandemic Tic‐like Behaviors Following Social Media ConsumptionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2932End Page: 2935Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28800Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28800Citation Count: 65
-
OPENTitle: Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning AnalysisJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 119End Page: 129Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28814Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/dc04516a-d43f-4a65-914b-0c5d09b9e5d8Citation Count: 25
-
OPENTitle: Special Issue on new therapeutic approaches to Parkinson diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 208Issue #:Start Page: 108998End Page: 108998Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.108998Citation Count: 5
-
OPENTitle: Spontaneous changes in brain striatal dopamine synthesis and storage dynamics ex vivo reveal end-product feedback-inhibition of tyrosine hydroxylaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 212Issue #:Start Page: 109058End Page: 109058Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.109058Best OA location URL: https://doi.org/10.1016/j.neuropharm.2022.109058Citation Count: 8